 Randomization will depend on inclusionexclusion criteria, taking into account the confirmation of diagnosis by the direct mycological test performed during the screening phase. However, cases whose diagnosis is not additionally confirmed by positive fungal culture sampled during the screening phase will be excluded from the efficacy analysis. 